Revenue Comparison
Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Sanofi 13.284, Moderna 0.145.
Sanofi vs Moderna Net Worth and Market Cap
Sanofi (SNY) and Moderna (MRNA) are peers in Vaccines. Sanofi reported revenue of $13.3B as of Q2 2026, compared with $145M for Moderna. Sanofi leads on revenue.
Sanofi's gross margin is 75.5% versus 35.9% for Moderna. Sanofi's net margin is 2.8% versus -539.3% for Moderna.
Key differences
- Revenue growth from Q2 2025 to Q2 2026: Sanofi +14.6%, Moderna +2.1%.
- Sanofi made an operating profit in its latest quarter (19.4% margin); Moderna made an operating loss (-562.1%).
- Sanofi's KPIs on Sterling include Beyfortus Net Sales (Quarterly) and Dupixent Net Sales by Region (Quarterly).
- Moderna's KPIs on Sterling include Cash, Cash Equivalents and Investments (Quarterly) and Net Product Sales vs Deferred Revenue (Quarterly).
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Sanofi, Moderna.| Metric | Sanofi | Moderna |
|---|---|---|
| Market Cap | - | - |
| Revenue | $13.28B | $145.00M |
| Cost of Revenue | $3.26B | $93.00M |
| Gross Profit | $10.03B | $52.00M |
| Operating Income | $2.58B | $-815.00M |
| Net Income | $370.00M | $-782.00M |
| R&D Expense | $2.41B | $651.00M |
| Earnings Per Share | $0.15 | -$1.96 |
| Gross Margin | 75.5% | 35.9% |
| Operating Margin | 19.4% | -562.1% |
| Net Profit Margin | 2.8% | -539.3% |
| Free Cash Flow | $4.22B | $-563.00M |
| Cumulative Free Cash Flow | $51.81B | $7.37B |
| Operating Cash Flow | $5.85B | $-526.00M |
| Cash & Equivalents | $6.86B | $1.72B |